Drug Use Investigation for ALLERMIST

• Status: Completed
• Trial end date: 2011-05-01
• Target enrollment: 0
• Participant gender: All

Summary

To investigate possible problems or questions in safety and efficacy of ALLERMIST Nasal Spray in Japanese subjects with allergic rhinitis under the practical use conditions

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Fluticasone

Criteria

Inclusion Criteria:

• Diagnosis of allergic rhinitis

• Use ALLERMIST for the first time

• Expected to use ALLERMIST for long-term (1 year)

Exclusion Criteria:

• Subjects with infection which fluticasone is not effective

• Subjects with deep mycosis

• Subjects with hypersensitivity to fluticason